A Pilot Trial of NY-ESO-1-Specific T Cells in Patients With Metastatic NY-ESO-1-Expressing Sarcomas Receiving Palliative Radiation
Phase of Trial: Phase I
Latest Information Update: 07 Jul 2017
At a glance
- Drugs NTBI 1301 (Primary)
- Indications Sarcoma
- Focus Adverse reactions
- 10 Jun 2017 Biomarkers information updated
- 10 Jan 2017 Status changed from active, no longer recruiting to completed.
- 09 Dec 2016 Status changed from recruiting to active, no longer recruiting.